High Risk HLA-A2 Melanoma的临床试验
总计636个结果
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)招聘中
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)终止
-
University Health Network, TorontoTakara Bio Inc.主动,不招人黑色素瘤 | 食道癌 | 卵巢癌 | 肺癌 | 膀胱癌 | 肝癌 | 滑膜肉瘤 | 在 HLA-A2 阳性患者中表达 NY-ESO-1 的实体瘤加拿大
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Bristol-Myers Squibb完全的高危 III 期黑色素瘤意大利, 波兰, 英国, 美国, 荷兰, 西班牙, 澳大利亚, 法国, 德国, 加拿大, 俄罗斯联邦, 比利时, 挪威, 瑞士, 瑞典, 芬兰, 奥地利, 丹麦, 捷克语
-
Memorial Sloan Kettering Cancer CenterTel-Aviv Sourasky Medical Center; Sheba Medical Center; Princess Alexandra Hospital, Brisbane,...主动,不招人
-
New York City Health and Hospitals CorporationNew York State Department of Health完全的
-
Array BioPharma完全的反洗钱 | 晚期和选定的实体瘤 | 高风险和极高风险 MDS美国, 澳大利亚, 意大利, 西班牙, 法国, 瑞士, 英国
-
George Washington UniversityUniversity of North Carolina, Chapel Hill; Aga Khan University; Kenya Medical Research Institute; Christian Medical College, Vellore, India 和其他合作者招聘中
-
London School of Hygiene and Tropical MedicineRawalpindi Medical College完全的
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Illinois... 和其他合作者完全的
-
University of British ColumbiaNational Institutes of Health (NIH)完全的
-
Oregon Health and Science UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
University of Texas Southwestern Medical Center完全的
-
Mount Sinai Hospital, CanadaOntario Mental Health Foundation未知
-
VIVE - The Danish Center for Social Science ResearchYale University; Metodecentret - Center for Effective Innovation in Social Services招聘中
-
The University of Texas Health Science Center,...Merck Sharp & Dohme LLC主动,不招人
-
Università Politecnica delle Marche完全的
-
Centre Hospitalier Universitaire de Saint Etienne终止
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Abbott Medical Devices完全的